Pacira | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Astellas Pharma JPY 418.89B 39.08B 2024-12
Bristol-Myers Squibb USD 9.13B 94M 2024-12
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
J&J USD 15.41B 102M 2024-12
Ligand Pharmaceuticals USD 39.98M 9.39M 2024-12
Novo Nordisk 60B 2.22B 2024-09
Pacira USD 147.37M 17.66M 2024-12
Perrigo USD 385.9M 18.5M 2024-12
Pfizer USD 12.11B 718M 2024-12
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
Teva Pharmaceutical Industries USD 2.12B 85M 2024-12
Xeris Pharmaceuticals USD 50.62M 9.95M 2024-12
Zoetis USD 1.61B 79M 2024-12



Pacira Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2025.